Insulin Resistance Syndrome: Clinical Trials

23 trials for Insulin Resistance Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 8 not yet recruiting, 3 recruiting, 2 unknown. 8 Not applicable, 3 Phase 2, 3 Phase 3, 2 Phase 4, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable8Completed 3, Not yet recruiting 2, Recruiting 2, Terminated 1
Phase 23Completed 2, Recruiting 1
Phase 33Unknown 2, Not yet recruiting 1
Phase 42Completed 2
Phase 11Recruiting 1

Follow Insulin Resistance Syndrome: new trials by email Literature Review of Insulin Resistance Syndrome trials Research Report on Insulin Resistance Syndrome

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Alpha-Lipoic Acid Added to Dapagliflozin and Insulin Resistance in Type 2 Diabetes
Alpha-Lipoic Acid (ALA), Placebo - Diabetes Mellitus, Type 2, Insulin Resistance Syndrome
Phase 3Not yet recruitingFayoum University702026-12-012026-11-12
Precision Exercise Using Myostatin/Follistatin Ratio in Obese Adults
Supervised Progressive Resistance Training, Standard Lifestyle Advice - Sarcopenic Obesity, Obesity & Overweight
Not applicableNot yet recruitingDiabetes Foundation, India2002026-12-012026-11-19
Biomarker Panel for PCOS-Associated Liver Steatosis in Adolescent Girls (COMPASS-pedPCOS)
Extended Serum Biomarker and Hormonal Panel, Liver Elastography with Controlled Attenuation Parameter, Targeted Genotyping of PNPLA3 rs738409 and HSD17B13 rs72613567 - Polycystic Ovary Syndrome (PCOS), Metabolic Dysfunction-Associated Steatotic Liver Disease
Not yet recruitingKayseri City Hospital1502026-09-012026-07-30
Non-Invasive Diagnostic Panel for MASLD in Children With Obesity
Non-Invasive Multi-Parameter Diagnostic Panel - Metabolic Dysfunction-Associated Steatotic Liver Disease, Pediatric Obesity
Not yet recruitingKayseri City Hospital1802026-07-012026-07-30
Cf-PWV and TyG Index Study
Hypertension, Insulin Resistance Syndrome
Not yet recruitingHospital de Base8002026-07-012026-05-22
SENSILINS: Impact of Cephalic Phase Insulin Release Induced by an Environmental Food Odor Stimulus on Glucose Homeostasis According to Insulin Sensitivity Level
Pleasant Food Odor Stimulation, Control Environmental Condition - Obesity & Overweight, Insulin Resistance Syndrome
Not applicableNot yet recruitingHospices Civils de Lyon202026-06-012026-06-10
CARTIZ Registry: Cartilage, Arthropathy and Imaging Under Tirzepatide in Zone-stratified Cohorts - A Four-Institute Mexican Observational Registry
Tirzepatide - Psoriatic Arthritis, Osteoarthitis
Not yet recruitingJULIO GRANADOS MONTIEL302026-05-012026-05-12
Artichoke By-products Rich in Hydroxycinnamic Acids and Mediterranean Diet for Type 2 Diabetes Prevention.
Artichoke by-product capsules, Energy-restricted Mediterranean diet (erMeDiet), Placebo capsules - Diabete Type 2, Obesity & Overweight
Not applicableRecruitingClinica Universidad de Navarra, Universidad de Navarra1502026-05-012026-04-29
Prevalenza Della Insulino Resistenza e Correlate Malattie Cardiovascolari Nella città di Napoli
No Intervention: Observational Cohort - Insulin Resistance Syndrome, Cardio Vascular Disease
CompletedComune di Napoli1237522026-01-252026-08-25
ENDOCARE-SCREEN: Metabolic Liver Dysfunction Screening Study
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH), Metabolic Syndrome
Not yet recruitingJarosław Drobnik100002026-01-052026-01-15
Gummy Candies With Maqui Berry
GM, Control, GMM - Overweight (BMI > 25), Obesity & Overweight
Not applicableCompletedGonzalo Jorquera, PhD102025-12-022026-01-28
Evaluation of MG53 (TRIM72) Levels in Women With Polycystic Ovary Syndrome: An Observational Study
No intervention (observational study) - Polycystic Ovary Syndrome (PCOS), Insulin Resistance Syndrome
Enrolling by invitationHavva Betül Bacak1282025-06-182025-08-06
Hyperbaric Oxygen Therapy on Insulin Resistance in Postmenopause
Hyperbaric oxygen therapy, Hypoglycemic Drug - Insulin Resistance Syndrome
Phase 1 / Phase 2RecruitingCairo University402025-01-282025-02-04
Prescription of Step Counts for Targeted Changes in Body Composition and Cardiometabolic Risk in Overweight/Obese Adults
Step counts for predictable changes in body weight/compositon and cardiometabolic risk - Dyslipidemia, Insulin Resistance Syndrome
Not applicableRecruitingKennesaw State University2002025-01-132025-10-27
Glycine Supplementation Improves Cognitive Performance in Mexican Older Adults
Glycine - Older Adults With Cognitive Decline, Insulin Resistance Syndrome
Not applicableCompletedBrenda Sarahí Beristain Lujano592024-12-012026-06-15
Relationship Between Metformin Treatment, Anemia, and Erythropoietin Levels in Women With Polycystic Ovary Syndrome in Jordan
Metformin - Polycystic Ovary Syndrome (PCOS) Women, Insulin Resistance Syndrome
Phase 4CompletedJerash Private University252023-06-012026-08-12
Diagnostic Interest of the IRAP Protein (Insulin Regulated Amino Peptidase) in Insulin Resistance
Dosage of IRAP during OGTT - Insulin Resistance Syndrome
Not applicableTerminatedUniversity Hospital, Grenoble212020-09-142022-08-11
A Extension Study of Empagliflozin in Patients With Refractory Diabetes Mellitus With Insulin Resistance ( EMPIRE-02 )
Empagliflozin Tablets - Insulin Resistance - Type A, Insulin Resistance - Type B
Phase 3UnknownKobe University82020-02-012021-06-03
Causal Mechanisms in Adolescent Arterial Stiffness
CS+, CS- - Lipid Disorder, Dyslipidemias
Phase 2CompletedBaylor College of Medicine722020-02-012026-11-02
A Study of Empagliflozin in Patients With Refractory Diabetes Mellitus With Insulin Resistance
Empagliflozin Tablets - Insulin Resistance - Type A, Insulin Resistance - Type B
Phase 3UnknownKobe University82019-09-012021-03-03

Showing 20 of 23. Sign in to see all of them.

Narrower conditions

Metabolic Syndrome (23)  ·  Insulin Resistance (10)  ·  Obesity (7)  ·  Overweight (6)  ·  Diabetes Mellitus, Type 2 (4)  ·  Diabetes Mellitus (3)  ·  Pediatric Obesity (3)  ·  Polycystic Ovary Syndrome (3)  ·  Coronary Artery Disease (2)  ·  Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans (2)  ·  Diabetes Mellitus, Lipoatrophic (2)  ·  Dyslipidemias (2)  ·  Fatty Liver (2)  ·  Hypertension (2)  ·  Non-alcoholic Fatty Liver Disease (2)

Broader conditions

Glucose Metabolism Disorders (23)  ·  Metabolic Diseases (23)  ·  Nutritional and Metabolic Diseases (23)  ·  Hyperinsulinism (22)  ·  Insulin Resistance (13)  ·  Pathological Conditions, Signs and Symptoms (11)  ·  Body Weight (10)  ·  Nutrition Disorders (10)  ·  Overnutrition (10)  ·  Signs and Symptoms (10)  ·  Endocrine System Diseases (9)  ·  Cardiovascular Diseases (4)  ·  Overweight (4)  ·  Vascular Diseases (4)  ·  Adnexal Diseases (3)

Interventions

Exercise (2)  ·  Hypoglycemic Agents (2)  ·  empagliflozin (2)  ·  (1-6)-alpha-glucomannan (1)  ·  Angiotensin-Converting Enzyme Inhibitors (1)  ·  Anti-Inflammatory Agents, Non-Steroidal (1)  ·  Aspirin (1)  ·  Bisoprolol (1)  ·  Dietary Fiber (1)  ·  Glycine (1)  ·  Hyperbaric Oxygenation (1)  ·  Hypolipidemic Agents (1)  ·  Isosorbide Dinitrate (1)  ·  Metformin (1)  ·  Observation (1)

Sponsors

Cairo University (2)  ·  Kayseri City Hospital (2)  ·  Kobe University (2)  ·  Baylor College of Medicine (1)  ·  Brenda Sarahí Beristain Lujano (1)  ·  Clinica Universidad de Navarra, Universidad de Navarra (1)  ·  Comune di Napoli (1)  ·  Diabetes Foundation, India (1)  ·  Fayoum University (1)  ·  Gonzalo Jorquera, PhD (1)  ·  Havva Betül Bacak (1)  ·  Hospices Civils de Lyon (1)  ·  Hospital de Base (1)  ·  JULIO GRANADOS MONTIEL (1)  ·  Jarosław Drobnik (1)

Countries

Egypt (3)  ·  Turkey (Türkiye) (3)  ·  France (2)  ·  Japan (2)  ·  Mexico (2)  ·  United States (2)  ·  Brazil (1)  ·  Chile (1)  ·  India (1)  ·  Italy (1)  ·  Jordan (1)  ·  Poland (1)  ·  Spain (1)  ·  Ukraine (1)

Top investigators

Wataru Ogawa (2)  ·  Andres Moron, PhD (1)  ·  Iziar Ludwig, PhD (1)  ·  Julio Granados-Montiel, MD, PhD (1)  ·  Justin P Zachariah, MD MPH (1)  ·  Marwin Gutierrez, MD (1)  ·  Professor Anoop Misra, MD (1)  ·  Robert Buresh, PhD (1)  ·  Sherif T Ahmed, teaching assistant (1)

Results publications

PMID 18820647, PMID 26511519, PMID 37364790, PMID 12493255, PMID 12642361, PMID 14698999, PMID 15741351, PMID 16775236, PMID 18064739, PMID 18511656, PMID 18852641, PMID 19067533, PMID 19268270, PMID 19585618, PMID 20338492, PMID 20624171, PMID 20808246, PMID 20888433, PMID 20937968, PMID 21274322, PMID 22048570, PMID 22157565, PMID 22278144, PMID 22916099, PMID 23519954, PMID 23592667, PMID 23840612, PMID 24029863, PMID 24886823, PMID 25156170, PMID 25199852, PMID 25333031, PMID 26160955, PMID 26512983, PMID 27660603, PMID 27901631, PMID 28107283, PMID 28701474, PMID 29562163, PMID 29872338, PMID 30170852, PMID 30267166, PMID 30827125, PMID 31002414, PMID 31030201, PMID 31255652, PMID 31381969, PMID 31466622, PMID 32008430, PMID 32020770

NIH funding

R01HL148217 (1)